Teva Pharmaceutical Industries Limited, our parent company, was founded as a wholesale drug business in 1901 in Jerusalem. Teva started building local pharmaceutical plants in Israel in 1930. After a rich and successful history of acquisitions, mergers and joint ventures, today Teva Pharmaceutical Industries Limited is one of the top 20 pharmaceutical companies in the world, specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals, as well as active pharmaceutical ingredients. With operations in over 60 countries and approximately 36,000 employees worldwide, the company offers the widest range of cost-effective pharmaceuticals, both generic and branded, to consumers, customers and healthcare providers. Teva s Innovative R&D efforts are currently focused on therapies for the central nervous system (with a focus on Multiple Sclerosis), autoimmune diseases and oncology. Teva deploys significant and increasing global reach in IR&D, with initiatives taking place in 27 countries around the world, including 14 Teva R&D sites (Israel, U.S., Canada, Mexico, Argentina, Austria, Belgium, Germany, France, Italy, Netherlands, Spain, U.K., Hungary). Teva differentiates itself by balancing its portfolio with generic as well as innovative activities, by the strategic depth of its vertical integration, by combining local customer responsiveness with a "global edge," by its geographic spread and by successfully managing increasing profitable growth and complexity. Backed by over 100 years of experience in the pharmaceutical industry, Teva believes that its success lies in the leadership of their management, the skills and devotion of their people, the quality of their offerings and their focus on customers and patients. In Canada, Teva Canada Limited, located in Toronto and formerly known as Teva Novopharm, is responsible for generic products while Teva Canada Innovation, with our head office in Montreal, is responsible for all innovative products in Canada. To learn more about the TEVA environment, we invite you to visit the Teva Pharmaceutical Industries Limited and Teva Canada Limited official websites. Shared Solutions ® is a unique and personalized support program available to anyone touched by MS. Anyone with an interest in MS can access Shared Solutions ® by calling 1 800-283-0034, Monday to Friday, 8:00 AM EST to 8:00 PM EST, in order to benefit from the insight of certified nurse consultants. Learn more
Teva Canada Innovation is Montreal-based company (Quebec, Canada) with a phone number 5148780095. Our data show that the company is located at the address: 999 boul de Maisonneuve O. The company has a web site: www.tevacanadainnovation.com.
Unfortunately сompany staff has not yet provided of company's activities, mission and detailed description.